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Abstract
Background: Transcription factors and nuclear receptors constitute a link between exposure to heterocyclic
amines and polycyclic aromatic hydrocarbons from meat and tobacco smoke and colorectal cancer (CRC) risk. The
aim of this study was to investigate if polymorphisms in nuclear factor kappa-B, pregnane X receptor, and liver X
receptor were associated with risk of CRC, and to investigate possible interactions with lifestyle factors such as
smoking, meat consumption, and NSAID use.
Methods: The polymorphisms nuclear factor kappa-B (NFkB, NFKB1) -94 insertion/deletion ATTG (rs28362491),
pregnane X receptor (PXR, NR1I2) A-24381C (rs1523127), C8055T (rs2276707), A7635G (rs6785049), liver X receptor
(LXR-b, NR1H3) C-rs1405655T, T-rs2695121C were assessed together with lifestyle factors in a nested case-cohort
study of 378 CRC cases and 756 random participants from the Danish prospective Diet, Cancer and Health study of
57,053 persons.
Results: Carriers of NFkB -94deletion were at 1.45-fold higher risk of CRC than homozygous carriers of the insertion
allele (incidence rate ratio (IRR) = 1.45, 95% confidence interval (95% CI): 1.10-1.92). There was interaction between
this polymorphism and intake of red and processed meat in relation to CRC risk. Carriers of NFkB -94deletion were
at 3% increased risk pr 25 gram meat per day (95% CI: 0.98-1.09) whereas homozygous carriers of the insertion
were not at increased risk (p for interaction = 0.03). PXR and LXR polymorphisms were not associated with CRC risk.
There was no interaction between use of nonsteroid antiinflammatory drugs (NSAID) or smoking status and NFkB,
PXR or LXR polymorphisms.
Conclusions: A polymorphism in NFkB was associated with CRC risk and there was interaction between this
polymorphism and meat intake in relation to CRC risk. This study suggests a role for NFkB in CRC aetiology.
Background
Colorectal cancer (CRC) constitutes the second most
common cause of all cancer-related incidence and mor-
tality in the Western World [1]. Risk factors include diet,
lifestyle factors and genetic predisposition and as much
as 50% of the CRC etiology has been attributed to diet
[1,2]. Intake of red and processed meat is a risk factor for
CRC and Danes have the highest meat intake per capita
in the World [1,3,4]. The exact mechanisms by which
intake of meat and processed meat promotes carcinogen-
e s i si sn o tc l e a r[ 5 ] .R e da n dp r o c e s s e dm e a tr e p r e s e n t
sources of carcinogenic heterocyclic amines (HCA), poly-
cyclic aromatic hydrocarbons (PAH) as well as N-nitroso
compounds caused by cooking at high temperature and
by processing of meat [5]. Moreover, heme in meat may
cause oxidative stress, oxidative DNA damage and carci-
nogenesis [6]. Tobacco smoking has also been reported
to confer risk of CRC [7,8] and Danes have a high preva-
lence of smokers [9,10]. Tobacco contains a large number
of mutagenic and carcinogenic compounds, including
PAH, nitrosamines, and nicotine [11]. PAHs and other
carcinogens from tobacco smoke may reach the intestinal
lumen after swallowing of inhaled particles and smoke
carcinogens may then be taken up the same way as meat
carcinogens. Long term use of aspirin and other non-
steroidal anti-inflammatory drugs (NSAID) has been
found to confer protection against CRC [12,13]. Impor-
tant mechanisms may be induction of apoptosis in CRC
cells by a NFkB dependent pathway as well as suppres-
sion of inflammation [14,15].
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novel insights into the pathogenesis of CRC [16-19]. We
have recently found interaction between meat intake
and polymorphisms in the ATP-binding cassette (ABC)
transporter B1 (ABCB1, MDR1) which encodes glyco-
protein P involved in reverse transport of carcinogens
and other xenobiotic substances [20]. The expression of
human MDR1 is regulated by pregnane X receptor
(PXR) and nuclear factor-B (NFkB) [21] whereas other
xenobiotic transporters such as ABCC2 (MRP2) seem to
be regulated by PXR and Liver X receptor (LXR) and
ABCG2 (BCRP) by Peroxisome Proliferator-Activated
Receptor g (PPARg) [21-24].
In relation to cancer development, the most important
effects of NFkB activation by tobacco smoke, PAH and
bacterial components is considered to be inhibition of
cell apoptosis caused by the increased transcription of
g e n e ss u c ha si n t e r l e u k i n1 - b (IL-1b) and cyclooxygen-
ase-2 (COX-2) [25,26]. Such a role for NFkB in tumor
promotion is supported by the lower tumor incidence
and size of tumors after inactivation of NFkB in animal
studies [27]. On the other hand, functional NFkB seem to
be required to control inflammation [28,29] and IL-1b
expression [30] and to induce apoptosis [15]. A func-
tional ATTG insertion/deletion (ins/del) polymorphism
in the promoter region of NFkB gene was associated with
lower transcription levels of the del-allele in luciferase
reporter systems [31] and risk of CRC in a Swedish, but
not in a Chinese study population [32].
Activation of PXR by xenobiotica, including carcino-
gens, leads to up-regulation of enzymes and transporters
involved in carcinogen handling including MDR1 [33]
and to repression of NFkB and other pro-carcinogenic
g e n e s[ 3 4 ] .P e r s o n sh omozygous for the PXR A7635G
(rs2276707) G-allele and persons carrying at least one
PXR C8055T (rs6785049) T-allele have significant higher
levels of intestinal CYP3A level following in vivo treat-
ment with the inducer rifampin than the homozygous
wildtype carriers [35]. Activation of LXR by fatty acids,
bacteria and cytokines leads to repression of pro-carci-
nogenic genes as IL-1b,C O X - 2 , MMP-9 and NFkB [36].
The LXR-b marker polymorphisms rs1405655 and
rs2695121 have been investigated as risk genes for Alz-
heimers disease with negative results [37].
We hypothesized that carriers of the NFB -94del
allele and PXR A7635G A-allele and C8055T C-allele
would be at higher risk of CRC, especially among smo-
kers and with high intake of red meat, whereas a protec-
tive effect of nonsteroid antiinflammatory drugs
(NSAID) use was expected. We investigated the associa-
tion between polymorphisms in NFkB (NFkB1) -94
insertion/deletion ATTG (rs28362491), PXR (NR1I2)
A-rs1523127-C, C-rs2276707-T, A-rs6785049-G, LXR
(NR1H2) C-rs1405655-T, T-rs2695121-C and risk of
CRC, as well as interactions between genes and con-
sumption of red and processed meat, smoking status
and use of NSAID in relation to the development of
CRC, in a case-cohort study nested in the prospective
population-based Danish Diet, Cancer and Health study.
Methods
Studied Subjects
The subjects were selected from the Danish Diet, Can-
cer and Health study, an ongoing prospective cohort
study [38]. Between December 1993 and May 1997,
160,725 individuals aged 50 to 64 years, born in Den-
mark, living in the Copenhagen and Aarhus areas and
having no previous cancers at the time of invitation,
were invited to participate in the study. A total of
57,053 persons accepted the invitation.
The colorectal cancer study group has been described
previously [17,19,20,39,40].
In total, 405 cases (184 women and 221 men) of col-
orectal cancer were diagnosed among the cohort mem-
bers between 1994 and 2003 and registered in the files
of the nationwide Danish Cancer Registry [19]. Within
the cohort we defined a sub-cohort sample including
368 women and 442 men who were randomly selected.
C a s e sa n dt h es u b - c o h o r ts a m p l ew e r ef r e q u e n c y -
matched on gender. Blood samples were available for
397 cases and 800 sub-cohort members. The numbers
of unknown genotypes were 16 and 37 and the numbers
of unavailable food frequency questionnaire were 11 and
17, among cases and sub-cohort members, respectively.
All information on genotypes and lifestyle factors was
available for 378 cases and 756 sub-cohort members
who were included in the statistical analyses. A flow
chart is shown in Figure 1.
Lifestyle variables
At enrolment, detailed information on diet, lifestyle,
weight, height, medical treatment, environmental expo-
sures, and other socio-economic factors were collected
[38]. In the food-frequency questionnaire, meat con-
sumption was assessed in 12 categories of predefined
responses, ranking from ‘never’ to ‘eight times or more
per day’. The daily intake was then calculated by using
FoodCalc [41], a program which uses population specific
standardized recipes and portion sizes. Intake of red
meat in grams per day was calculated by adding up
intake of beef, veal, pork, lamb and offal. Intake of pro-
cessed meat in grams per day was calculated by adding
up intake of processed red meat, including bacon,
smoked ham, salami, frankfurter, Cumberland sausage,
cold cuts and liver pâté. Total dietary fibers are calcu-
lated by the AOAC methods [42]. Pearson correlation
coefficients (adjusted for total energy intake) illustrating
the comparison of nutrient scores estimated from the
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were 0.39 and 0.53 for dietary fibers, 0.56 and 0.48 for
iron, and 0.37 and 0.14 for meat for men and women,
respectively [43,44].
Smoking status was categorized in three categories,
never smoker, past smoker and current smoker based
on the questionnaire.
The lifestyle questionnaire included questions regard-
ing use of specific types of NSAID [45]. Based on all
records, we classified study subjects according to use of
“any NSAID” (≥ 2 pills per month during one year) at
baseline.
Data on hormone replacement therapy (HRT), alcohol
intake and anthropometric measurements, and physical
activity was obtained from the questionnaire as pre-
viously described [38]. The body mass index (BMI) was
calculated as weight (kg) per height (m) squared.
Blood sampling and storage
Blood was collected at enrolment and prepared as pre-
viously described [46]. In short, a total of 30 ml blood was
collected in citrated (2 × 10 ml) and plain (1 × 10 ml)
Venojects from each non-fasting participant, and lympho-
cytes were isolated and frozen at -20°C within 2 hours.
Figure 1 A flow chart showing the selection of study subjects. Between December 1993 and May 1997, 160,725 individuals aged 50 to 64
years, born in Denmark, living in the Copenhagen and Aarhus areas and having no previous cancers at the time of invitation, were invited to
participate in the study. Please refer to Methods for further details.
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in liquid nitrogen, at -150 ˚C.
Genotyping
DNA was isolated from frozen lymphocytes as described
[ 4 7 ] .G e n e r a l l y ,1 0 0μg DNA were obtained from 10
7
lymphocytes.
Genotypes were determined by Taqman allelic discri-
mination (ABI 7500/7900HT, Applied Biosystems).
Twenty ng of DNA was analysed in 4 μl volumes. Cases
and sub-cohort members were mixed during genotyping
and laboratory staff was blinded to case/control status
during analysis. Triplicates of genotype controls of all
three genotypes were included in each run. The controls
were selected in pilot genotype determinations of DNA
from the same cohort. Ten % of the samples were ran-
domly selected and genotyped again for reproducibility
with 100% identity.
NFKB1 ATTG ins/del (rs28362491) was determined as
described [48]. Four μl reactions contained ca. 20 ng
DNA, 2 μl mastermix (Applied Biosystems, Birkerød,
Denmark), 100 nM of each probe and 900 nM primers.
Primer sequences were: F: 5’-CTA TGG ACC GCA
TGA CTC TAT CAG-3’ R: 5’-GGG CTC TGG CTT
CCT AGC A-3’. Probe sequences were: NFKB -INS:
5’-FAM-ACC ATT GAT TGG GCC CGG-BHQ-3’,
NFKB-del: 5’-Yakima Yellow-CCG ACC ATT GGG
CCC G-BHQ-3’.
PXR (NR1I2) A-24381C (rs1523127), C8055T
(rs2276707), A7635G (rs6785049), LXR-b (NR1H3)
C-rs1405655T, and T-rs2695121C were assayed using
pre-developed assays (Applied Biosystems).
Statistical Analysis
The analyses were performed according to the principles
for the analysis of case-cohort studies as described by
Barlow [49]. The analyses were performed unweighted.
Age was used as the time scale in the Cox regression
model. Tests and confidence intervals were based on
Wald’st e s tu s i n gt h er o b u s te s t i m a t eo ft h ev a r i a n c e -
covariance matrix for the regression parameters in the
Cox regression model [50].
All models were adjusted for baseline values of estab-
lished risk factors for colorectal cancer such as BMI
(kg/m
2, continuous), NSAID (yes/no), use of HRT
(never/past/current, among women), smoking status
(never/past/current), and intake of dietary fibers (g/day,
continuous), red meat (g/day, continuous), alcohol
intake (g/day, continuous), and physical activity (hours/
day, continuous).
We investigated possible interactions between the
genes and selected environmental factors using the like-
lihood ratio test. Tertiles of meat intake was defined as
bounderies of intake of red and processed meat among
the case group when devided into tertiles. Trend test
were calculated using the Wald test. The procedure
PHREG in SAS (release 9.1; SAS Institute Inc., Cary,
NC, USA) was used for the statistical analyses.
Ethics
All participants gave verbal and written informed con-
sent. Diet, Cancer and Health and the present sub-study
were approved by the regional Ethics Committees on
Human Studies in Copenhagen and Aarhus (Jr.nr. (KF)
11-037/01 and jr.nr. (KF)01-045/93), and by the Danish
Data Protection Agency.
Results
Characteristics of the study population and risk factors
for CRC are shown in Table 1. The genotype distribu-
tions among the participants in the sub-cohort sample
did not deviate from Hardy-Weinberg equilibrium
(results not shown).
Carriers of the NFkB -94del were at 1.45-fold (95%
confidence interval (CI): 1.10-1.92) higher risk of CRC
than homozygous carriers of the ins allele (Table 2)
whereas PXR and LXR genotypes were not associated
with CRC risk (Table 2). Haplotype analyses of the PXR
gene showed eight different haplotypes. The most fre-
quent haplotypes were the A-rs1523127-C/A- rs6785049-
G/C-rs2276707-T combinations showing CGC, AAC,
and the AGC which had frequencies of 0.12, 0.40 and
0.14, respectively. Haplotype analyses of the LXR gene
showed four different haplotypes. The frequencies were
for the C-rs1405655-T/T-rs2695121-C combinations TC,
TT, CT and CC 0.33, 0.30, 0.24, and 0.12, respectively.
No association was found between any of the eight PXR
or four LXR haplotypes and CRC (data not shown).
Since we observed no allele-dose effects, all variant
allele carriers were combined in subsequent analyses to
maximize the statistical power. Del-allele carriers of
NFkB -94ins/del were at 3% higher risk pr 25 g meat/
day (CI: 0.98-1.09) whereas among homozygous carriers
of the ins-allele, the association was in the opposite
direction (IRR pr 25 g/day: 0.97, CI: 0.90-1.04, p for
interaction= 0.03) (Table 3). Table 4 shows the IRRs for
tertiles of intake of red and processed meat subdivided
by the NFkB genotypes. Among homozygous ins-allele
carriers of the NFkB -94ins/del polymorphism, IRRs
were unchanged across tertiles of meat intake, whereas
for del-allele carriers, the risk of CRC was higher for the
second and the third tertile of meat intake compared to
the first tertile (Table 4). In this analysis, there was no
statistical significant interaction.
No interactions between smoking status or NSAID use
and the studied genotypes were found (Tables 5 and 6).
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Carriers of the del-allele of NFkB -94ins/del polymorph-
ism were at statistically significantly higher risk of CRC
than the homozygous carriers of the ins-allele.
Prospective studies have the advantage in relation to
examining gene-environmental interactions that they are
not encumbered by recall bias. In the present study,
cases and cohort sample were selected from the same
cohort, which together with complete follow up of the
participants minimised the risk of selection bias. We
have used the case-cohort study design in the present
study. The case-cohort analysis is a more flexible design
than a nested case-control design [49]. It permits us to
use one large, randomly selected comparison group as
comparison group for several nested studies within the
Diet, Cancer and Health cohort, saving resources and
valuable DNA, and the obtained risk estimates can be
related directly to the cohort, which is population-based.
We have previously used the same design in other
studies of colorectal cancer [17,19,20,39,51], lung cancer
[52-55], and coronary heart disease [56-59].
A main strength of our study is a well characterized
study population. Information on lifestyle factors were
collected at enrolment for all participants which mini-
mised the risk of differential misclassification of cases
and comparison group. However, lifestyle factors were
only collected once, and may thus not be representative
for the lifestyle during follow-up. This is, however, not
expected to result in differential misclassification.
Furthermore, information on food intake was based on
a semi-quantitatively food frequency questionnaire
[38,44], which was evaluated and found usable [43]. The
results were adjusted for known confounding factors
affecting the risk of CRC in this cohort including dietary
factors, body mass index (BMI), alcohol, smoking status,
physical activity and NSAID use [1]. An additional
strength of the present study is the high exposure of red
and processed meat and tobacco smoke in the present
Table 1 Baseline characteristics of study participants selected from the Danish Diet, Cancer and Health prospective
cohort study.
Cases Sub-cohort
No. (%) Median (5-95%) No. (%) Median (5-95%)
Total 378 (100) 756 (100)
Gender
Men 207 (55) 409 (54)
Women 171 (45) 347 (46)
Age at inclusion 58 (51-64) 56 (50-64)
Topology
Proximal segment of colon 42 (11)
Distal segment of colon 148 (39)
Rectal 136 (36)
Not specified 52 (14)
BMI 26 (21-34) 26 (21-33)
Food intake
Alcohol, g/day 14 (1-69) 13 (1-61)
Red meat, g/day 82 (37-171) 82 (32-177)
Processed meat, g/day 26 (6-79) 25 (4-76)
Dietary fibres g/day 20 (10-32) 21 (11-34)
Smoking status at inclusion
Never 116 (31) 250 (33)
Former 113 (30) 238 (31)
Present 149 (39) 268 (35)
NSAID use
No 123 (33) 234 (31)
Yes 255 (67) 522 (69)
HRT use among women
Never 100 (58) 186 (54)
Former 26 (15) 58 (17)
Present 45 (26) 103 (30)
Observed median values (5-95 percentiles) or percents of the distribution of baseline characteristics among cases and members of the comparison group.
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tively small sample size. Therefore, heterozygous and
homozygous variant genotype carriers were combined
for the analyses of interactions to obtain sufficient statis-
tical power. Nevertheless, in the light of the obtained P-
values and the number of statistical testes performed,
we cannot exclude that our positive findings may be due
to chance.
We found a weak interaction between NFkB -94ins/del
polymorphism and intake of red and processed meat in
relation to CRC risk (Table 3). In the interaction analy-
sis, we calculated the slopes of two curves describing
the relationship between meat intake and CRC risk for
homozygous carriers of the ins-allele and for carriers of
the del-allele, respectively. However, either of the slopes
is statistically significantly different from 1, as indicted
by the confidence intervals. However, the two slopes
were statistically significantly different from each other
as indicated by the p-value for the interaction
(p = 0.03). Furthermore, among homozygous carriers of
the ins-allele of the NFkB -94ins/del polymorphism, risk
of CRC was unchanged across tertiles of meat intake,
whereas for del-allele carriers, the risk of CRC was
higher for the second and the third tertile of meat
intake compared to the first tertile (Table 4). In this
analysis, there was no statistically significant interaction.
Our study thus suggests that the NFkB polymorphism
may be most important in study populations with high
consumption of red and processed meat. The NFkB
-94ins/del del-allele was associated with risk of CRC
among Swedes, whereas no association was found
among Chinese [32]. Hence, the difference between the
findings in the Danish and Swedish on one hand and
the Chinese on the other may be related to differences
Table 2 Incidence rate ratios (IRR) for colorectal cancer for the studied gene polymorphisms.
Ncases Nsub-cohort IRR
A 95% CI IRR
B 95% CI p-value
C
NFkB -94ins/del
II 121 307 1.00 - 1.00 - 0.03
ID 195 347 1.46 (1.10-1.93) 1.44 (1.07-1.92)
DD 62 102 1.50 (1.02-2.22) 1.50 (1.00-2.25)
ID and DD 257 449 1.47 (1.12-1.92) 1.45 (1.10-1.92)
PXR rs1523127
AA 127 257 1.00 - 1.00 - 0.78
AC 188 371 0.99 (0.74-1.31) 0.99 (0.74-1.32)
CC 63 128 1.08 (0.74-1.57) 1.12 (0.77-1.65)
AC and CC 251 499 1.01 (0.77-1.32) 1.02 (0.77-1.34)
PXR rs2276707
CC 237 441 1.00 - 1.00 - 0.66
CT 122 270 0.87 (0.67-1.14) 0.88 (0.67-1.17)
TT 19 45 0.83 (0.46-1.49) 0.89 (0.49-1.62)
CT and TT 141 315 0.87 (0.67-1.12) 0.88 (0.68-1.15)
PXR rs6785049
AA 136 259 1.00 - 1.00 - 0.60
AG 187 398 0.91 (0.69-1.21) 0.90 (0.67-1.21)
GG 55 99 1.10 (0.74-1.64) 1.09 (0.72-1.65)
AG and GG 242 497 0.95 (0.73-1.24) 0.94 (0.71-1.24)
LXR rs1405655
CC 169 347 1.00 - 1.00 - 0.88
CT 169 335 1.00 (0.77-1.31) 1.00 (0.76-1.31)
TT 40 74 1.05 (0.68-1.63) 1.12 (0.71-1.76)
CT and TT 209 409 1.01 (0.79-1.31) 1.02 (0.79-1.32)
LXR rs2695121
TT 117 221 1.00 - 1.00 - 0.36
CT 187 368 0.93 (0.69-1.25) 0.91 (0.67-1.23)
CC 74 167 0.78 (0.54-1.12) 0.77 (0.53-1.11)
CT and CC 261 535 0.88 (0.67-1.17) 0.86 (0.65-1.15)
ACrude (adjusted for age and sex).
BAdditionally adjusted for status of HRT (women only), smoking status, alcohol, dietary fibre, red meat, physical activity and BMI and NSAID use.
Cp-value for trend for the adjusted estimates.
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income countries, including Denmark and Sweden, com-
pared to low income countries, including China, respec-
tively [3].
We have previously found interaction between meat
intake and polymorphisms in the xenobiotic transporter
MDR1 in relation to CRC in this study group [20].
Combined carriers of MDR1 intron 3 G-rs3789243A A-
allele and NFkB -94ins/del del-allele have an IRR of 1.85
(95% confidence interval (CI): 1.15-3.00, p = 0.007) com-
pared to the homozygous G-allele and ins-allele carriers,
suggesting additive but no synergistic effect by having
both risk alleles. However, the statistical power to
explore gene-gene interactions was low. The two studies
m a ys u g g e s tt h a tal o w e rN F k Br e s p o n s eb yt h eNFkB
del-allele carriers after stimulation by intestinal carcino-
gens may lead to a lower expression of the MDR1 [21]
and, thus, a lower transport activity and, eventually, an
impaired defence against intestinal uptake of luminal
carcinogens compared to homozygous ins-allele carriers.
Furthermore, interaction between meat and NFkB may
be caused by a lower activation of NFkB del-allele rela-
tive to the ins-allele resulting in a high load of reactive
oxygen species provided by heme degradation and
which may contribute to carcinogenesis [60].
We found no interaction between the NFkB -94ins/del
polymorphism and smoking status, suggesting that the
carcinogen exposure from tobacco smoke, which comes
from ingestion of inhaled tobacco smoke particles, is
less than the carcinogen exposure from ingestion of red
Table 3 Incidence rate ratios (IRR) for colorectal cancer per additional intake of 25 g red or processed meat
subdivided by the studied genotypes.
Red and processed meat
Ncases Nsub-cohort IRR
A 95% CI IRR
B 95% CI p-value
C
NFkB -94ins/del
II 121 307 0.96 (0.90-1.03) 0.97 (0.90-1.04) 0.03
ID and DD 257 449 1.03 (0.98-1.08) 1.03 (0.98-1.09)
PXR rs1523127
AA 127 257 1.04 (0.98-1.12) 1.04 (0.97-1.12) 0.28
AC and CC 251 499 1.01 (0.96-1.06) 1.01 (0.96-1.07)
PXR rs2276707
CC 237 441 1.02 (0.97-1.08) 1.02 (0.97-1.08) 0.53
CT and TT 141 315 1.01 (0.95-1.07) 1.01 (0.94-1.08)
PXR rs6785049
AA 136 259 1.01 (0.95-1.07) 1.01 (0.95-1.08) 0.72
AG and GG 242 497 1.02 (0.97-1.08) 1.02 (0.97-1.08)
LXR rs1405655
CC 169 347 1.02 (0.97-1.07) 1.02 (0.96-1.08) 0.91
CT and TT 209 409 1.02 (0.96-1.08) 1.02 (0.96-1.08)
LXR rs2695121
TT 117 221 1.04 (0.98-1.12) 1.05 (0.97-1.12) 0.28
CT and CC 261 535 1.01 (0.96-1.07) 1.01 (0.96-1.07)
ACrude (adjusted for age and sex).
BAdditionally adjusted for status of HRT (women only), smoking status, alcohol, dietary fibre, physical activity, NSAID use and BMI.
Cp-value for interaction between genotype and red and processed meat for the adjusted estimates.
Table 4 Incidence rate ratios (IRR) for colorectal cancer for tertiles of intake of red and processed meat subdivided by
the NFkB genotypes.
Red and processed meat IRR
A 95% CI p-value
B
1. tertile 2. tertile 3. tertile Red and processed meat
NC NS NC NS NC NS <91.4 g/day 91.4-130.2 g/day >130.2 g/day
NFkB -94ins/del
II 46 107 35 98 40 102 1.00 - 0.88 (0.50-1.54) 1.07 (0.61-1.88) 0.16
ID and DD 78 157 91 137 88 155 1.19 (0.75-1.91) 1.70 (1.06-2.74) 1.44 (0.89-2.34)
AAdjusted for status of HRT (women only), smoking status, alcohol, dietary fibre, BMI, physical activity and NSAID use.
Bp-value for interaction.
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NSAID IRR
A 95% CI IRR
B 95% CI p-value
C
NO YES NSAID NSAID
NC NS NC NS NO YES NO YES
NFkB -94ins/del
II 83 210 38 97 1.00 - 1.09 (0.69-1.73) 1.00 - 1.03 (0.64-1.65) 0.82
ID and DD 172 312 85 137 1.47 (1.06-2.03) 1.60 (1.09-2.35) 1.43 (1.02-1.99) 1.55 (1.04-2.31)
PXR rs1523127
AA 83 172 44 85 1.00 - 1.09 (0.69-1.73) 1.00 - 1.07 (0.67-1.71) 0.99
AC and CC 172 350 79 149 1.01 (0.73-1.40) 1.11 (0.75-1.63) 1.02 (0.73-1.43) 1.09 (0.73-1.63)
PXR rs2276707
CC 161 296 76 145 1.00 - 1.01 (0.72-1.43) 1.00 - 0.96 (0.67-1.37) 0.25
CT and TT 94 226 47 89 0.81 (0.59-1.12) 1.01 (0.67-1.53) 0.81 (0.59-1.12) 1.02 (0.66-1.56)
PXR rs6785049
AA 90 180 46 79 1.00 - 1.11 (0.70-1.74) 1.00 - 1.07 (0.67-1.71) 0.98
AG and GG 165 342 77 155 0.96 (0.69-1.32) 1.04 (0.71-1.53) 0.94 (0.67-1.32) 1.00 (0.67-1.49)
LXR rs1405655
CC 117 238 52 109 1.00 - 1.00 (0.67-1.50) 1.00 - 0.94 (0.62-1.44) 0.32
CT and TT 138 284 71 125 0.96 (0.71-1.31) 1.13 (0.78-1.65) 0.95 (0.69-1.30) 1.12 (0.76-1.64)
LXR rs2695121
TT 85 161 32 60 1.00 - 1.08 (0.64-1.80) 1.00 - 1.02 (0.58-1.78) 0.75
CT and CC 170 361 91 174 0.87 (0.62-1.21) 0.97 (0.67-1.41) 0.84 (0.60-1.19) 0.93 (0.63-1.36)
ACrude (adjusted for age and sex)
BAdditionally adjusted for status of hormone replacement therapy (HRT), smoking status, alcohol, dietary fibre, red meat, physical activity and BMI.
C P-value for interaction for the adjusted estimates.
Table 5 Interaction between the studied polymorphisms and smoking status.
Smoking IRR
A 95% CI p-value
B
Never Past Current Smoking
NC NS NC NS NC NS Never Past Current
NFkB -94ins/del
II 37 101 37 101 47 105 1.00 - 0.89 (0.51-1.55) 1.15 (0.67-1.97) 0.84
ID and DD 79 149 76 137 102 163 1.45 (0.89-2.37) 1.41 (0.86-2.33) 1.55 (0.96-2.51)
PXR rs1523127
AA 33 94 42 76 52 87 1.00 - 1.37 (0.77-2.47) 1.55 (0.89-2.70) 0.08
AC and CC 83 156 71 162 97 181 1.49 (0.90-2.45) 1.15 (0.69-1.91) 1.38 (0.84-2.28)
PXR rs2276707
CC 63 141 70 135 104 165 1.00 - 1.01 (0.65-1.57) 1.24 (0.82-1.87) 0.43
CT and TT 53 109 43 103 45 103 1.06 (0.66-1.68) 0.89 (0.54-1.47) 0.93 (0.57-1.51)
PXR rs6785049
AA 40 89 38 85 58 85 1.00 - 0.92 (0.52-1.61) 1.37 (0.80-2.33) 0.28
AG and GG 76 161 75 153 91 183 1.06 (0.65-1.72) 1.00 (0.61-1.63) 1.04 (0.64-1.67)
LXR rs1405655
CC 49 117 54 116 66 114 1.00 - 0.93 (0.56-1.54) 1.18 (0.72-1.92) 0.83
CT and TT 67 133 59 122 83 154 1.07 (0.66-1.72) 1.01 (0.62-1.64) 1.11 (0.71-1.74)
LXR rs2695121
TT 36 74 35 63 46 84 1.00 - 1.12 (0.61-2.07) 1.20 (0.67-2.13) 0.67
CT and CC 80 176 78 175 103 184 0.98 (0.59-1.63) 0.85 (0.51-1.42) 1.03 (0.63-1.70)
AAdjusted for age, sex, status of hormone replacement therapy (HRT)(women only), alcohol, dietary fibre and BMI, physical activity and NSAID use.
B P-value for interaction.
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Page 8 of 11and processed meat. This is in accordance with our pre-
vious finding of smoking being a weaker risk factor for
CRC than red and processed meat [20].
We found no statistically significant associations
between the PXR and LXR polymorphisms and CRC
risk, and no interaction with smoking status, use of
NSAID, or intake of red and processed meat. These two
genes have not previously been investigated in relation
to CRC. We had from 73% to 99% chance to detect a
dominant effect of the three studied polymorphisms in
PXR using the ORs from the study of Dring [61] of 1.3-
2.9 and similarly more than 84% chance of detecting a
dominant effect with an OR of 1.5 in LXR. Our findings
do therefore not support important roles of PXR and
LXR in CRC etiology. This is in accordance with the
observation that NFkB activation suppress the action of
PXR and vice versa [62,63].
We found no interaction between NSAID use and
NFB, PXR and LXR genotypes. A risk reducing affect
of NSAID may be dependent on functional NFB, as
aspirin has been shown to induce apoptosis in intestinal
cell lines by a NFB dependent mechanism [64]. Long-
term use of NSAID was associated with a protective
effect against CRC in the “Diet, Cancer and Health”
cohort, used in the present study [45]. Hence, the
results do not support important roles of the studied
genotypes in interaction with NSAID in CRC aetiology.
Conclusions
The present study indicated that the ins/del NFkB poly-
morphism may be involved in CRC etiologi. The ins/del
NFkB polymorphism may affect the risk of CRC by
exposure of meat as carriers of the NFkB del-allele were
more susceptible to meat carcinogens than homozygous
ins-allele carriers. This is the first study finding interac-
tion between NFkB and meat intake in relation to CRC.
However, the findings must be further evaluated in large
populations with high meat intake.
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